Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-008300
Filing Date
2025-02-26
Accepted
2025-02-26 10:20:24
Documents
88
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2075574
2 ex21.htm EX-21 2553
3 ex23-1.htm EX-23.1 3201
4 ex31-1.htm EX-31.1 13380
5 ex31-2.htm EX-31.2 13391
6 ex32-1.htm EX-32.1 7637
7 ex32-2.htm EX-32.2 7677
8 form10-k_001.jpg GRAPHIC 107978
9 form10-k_002.jpg GRAPHIC 155046
10 form10-k_003.jpg GRAPHIC 106718
11 form10-k_004.jpg GRAPHIC 169873
12 form10-k_005.jpg GRAPHIC 15839
13 form10-k_006.jpg GRAPHIC 22737
14 form10-k_007.jpg GRAPHIC 282786
  Complete submission text file 0001493152-25-008300.txt   10779668

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE shph-20241231.xsd EX-101.SCH 52972
16 XBRL CALCULATION FILE shph-20241231_cal.xml EX-101.CAL 70368
17 XBRL DEFINITION FILE shph-20241231_def.xml EX-101.DEF 274367
18 XBRL LABEL FILE shph-20241231_lab.xml EX-101.LAB 519172
19 XBRL PRESENTATION FILE shph-20241231_pre.xml EX-101.PRE 425253
91 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1073363
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41488 | Film No.: 25667055
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)